Amyloidosis trials in Netherlands
6 of 17 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Where
- Groningen
- People
- 1,500 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT04561518 - No phaseTaking peoplePatisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
- Where
- Groningen
- People
- 10 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT05040373 - No phaseTaking peopleQuantitative-imaging in Cardiac Transthyretin Amyloidosis
- Where
- Groningen
- Age
- 40 years and over
- People
- 140
- Run by
- University of Edinburgh
See details and how to joinNCT05776212 - No phaseTaking peopleA EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
- Where
- Utrecht
- Age
- 18 years to 99 years
- People
- 400 worldwide
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06205953 - No phaseTaking peopleInternational Cardiac Amyloidosis Registry
- Where
- Leiden
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT06894290 - No phaseTaking peopleA Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
- Where
- Utrecht
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06836011